期刊文献+

婴幼儿极长链酰基辅酶A脱氢酶缺陷症5例诊治特点分析 被引量:2

下载PDF
导出
摘要 目的探讨婴幼儿极长链酰基辅酶A脱氢酶(VLCAD)缺陷症的临床诊断和治疗方法。方法对5例VLCAD缺陷症患儿的临床表现、实验室检查及治疗与转归进行分析。结果患儿表现为反复抽搐、智力落后、肌力低下、肝脏肿大和肌酸激酶显著增高等,严重者急剧恶化昏迷,迅速死亡。本组5例患儿中均见乙酰基肉碱(C2)水平明显降低,月桂酰基肉碱(C12)、肉豆蒄酰基肉碱(C14)和肉豆蒄烯酰基肉碱(C14∶1)显著增高。本症无特殊治疗,基因治疗仍处于实验阶段。结论应用串联质谱技术检测血中酰基肉碱水平可对脂肪酸代谢病高危新生儿进行筛查和确诊,治疗主要通过高糖饮食、辅以中链脂肪酸,限制长链脂肪酸的摄入。
出处 《广东医学》 CAS CSCD 北大核心 2012年第15期2280-2281,共2页 Guangdong Medical Journal
  • 相关文献

参考文献7

  • 1SPIEKERKOETTER U,LINDNER M,SANTER R,et al.Treatment recommendations in long-chain fatty acid oxidation defects:consensus from a workshop[J].J Inherit Metab Dis,2009,32(4):498-505.
  • 2韩连书,叶军,邱文娟,高晓岚,王瑜,张拥军,顾学范.串联质谱技术在脂肪酸氧化代谢病诊断中的应用研究[J].中华医学遗传学杂志,2007,24(6):692-695. 被引量:11
  • 3KOREMATSU S,KOSUGI Y,KUMAMOTO T,et al.Novel mutation of early,perinatal-onset,myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency[J].Pediatr Neurol,2009,41(2):151-153.
  • 4ZHANG D,CHRISTIANSON J,LIU Z X,et al.Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency[J].Cell Metab,2010,11(5):402-411.
  • 5HOFFMANN L,HAUSSMANN U,MUELLER M,et al.VLCAD enzyme activity determinations in newborns identified by screening:a valuable tool for risk assessment[J].J Inherit Metab Dis,2012,35(2):269-277.
  • 6TER VELD F,MUELLER M,KRAMER S,et al.A novel tandem mass spectrometry method for rapid confirmation of medium-and very long-chain acyl-CoA dehydrogenase deficiency in newborns[J].PLoS One,2009,4(7):e6449.
  • 7KEELER A M,CONLON T,WALTER G,et al.Long-term Correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy[J].Mol Ther,2012,20(6):1131-1138.

二级参考文献11

  • 1韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:62
  • 2Sim KG, Hammond J, Wilcken B. Strategies for the diagnosis of mitochondrial fatty acid β-oxidatlon disorders. Clin Chim Acta, 2002,323:37-58.
  • 3Feuchtbaum L, Lorey F,Faulkner L, et al. Califomia's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry. Pediatrics, 2006,117:261-269.
  • 4Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: Clinical and laboratory aspects. Clin Biochem, 2006, 39:315-332.
  • 5Yoon HR, Lee KR, Kan S, et al. Screening of newborns and high-risk group of children for inbom metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta, 2005, 354 :167-180.
  • 6Hoffmann GF, Kries RD, Klose D, et al. Frequencies of inherited organic aeidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Ear J Pediatr, 2004, 163:76-80.
  • 7Waddell L, Wiley V, Carpenter K, et cd. Medium-chain acyl-CoA dehydrogenase defiency: genotype-biochemical phenotype correlations. Mol Genet Metab, 2006, 87 : 32-39.
  • 8Fingerhut R, Roschinger W, Muntau AC, et al. Hepatic camitine palmitoyltransferase Ⅰ deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem, 2001, 47:1763-1768.
  • 9Gempel K, Kiechl S, Hofmann S, et al. Screening for camitine palmitoyltransferase Ⅱ deficiency by tandem mass spectrometry. J Inherit Metab Dis, 2002, 25:17-27.
  • 10Shigematsu Y, Hirano S, Hata I, et al. Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination. J Chromatogr B Analyt Technol Biomed Life Sci, 2003, 792: 63-72.

共引文献10

同被引文献33

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部